Market Value4,417,403,494
Total Holdings59
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
HLVX / HilleVax, Inc.
DALS / DA32 Life Science Tech Acquisition Corp - Class A
SCPH / scPharmaceuticals Inc.
DICE / DICE Therapeutics Inc
BIIB / Biogen Inc.
IOBT / IO Biotech, Inc.
CVAC / CureVac N.V.
WVE / Wave Life Sciences Ltd.
ELYM / Eliem Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
/ Fusion Networks Holdings, Inc.
VRDN / Viridian Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
GHRS / GH Research PLC
SPRY / ARS Pharmaceuticals, Inc.
PEPG / PepGen Inc.
IMUX / Immunic, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
AADI / Aadi Bioscience, Inc.
THRD / Third Harmonic Bio, Inc.
AKRO / Akero Therapeutics, Inc.
CNCE / Concert Pharmaceuticals Inc
IMGN / ImmunoGen, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
ATHA / LeonaBio, Inc.
NSTG / NanoString Technologies, Inc.
ITOS / iTeos Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
BDTX / Black Diamond Therapeutics, Inc.
CNTB / Connect Biopharma Holdings Limited
ARYE / ARYA Sciences Acquisition Corp V - Class A
EYPT / EyePoint, Inc.
CVRX / CVRx, Inc.
ENTX / Entera Bio Ltd.
ANTX / AN2 Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
RCKT / Rocket Pharmaceuticals, Inc.
KNTE / Kinnate Biopharma Inc.
PCVX / Vaxcyte, Inc.
TVTX / Travere Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
STSA / Satsuma Pharmaceuticals Inc
TYRA / Tyra Biosciences, Inc.
AVTE / Aerovate Therapeutics, Inc.
ACRV / Acrivon Therapeutics, Inc.
CELC / Celcuity Inc.
CTKB / Cytek Biosciences, Inc.
INBX.V / Inhibrx, Inc.
NKTX / Nkarta, Inc.
NAMS.W / NewAmsterdam Pharma Company N.V. - Equity Warrant
HOWL / Werewolf Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
MLYS / Mineralys Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
TNYA / Tenaya Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
RNA / Atrium Therapeutics, Inc.
BLU / BluEnergies Ltd.
ICVX / Icosavax, Inc.
RXST / RxSight, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
PLRX / Pliant Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
GERN / Geron Corporation
ETNB / 89bio, Inc.
JANX / Janux Therapeutics, Inc.
VOR / Vor Biopharma Inc.
ASND / Ascendis Pharma A/S
ELVN / Enliven Therapeutics, Inc.